Cristina Legido Quigley
  • Phone84722
  • 4888

Personal profile

Biographical details

  • The Clinical Biomarkers lab has been based in KCL since 2006, headed by Dr Legido-Quigley the lab is equiped with HPLC-UV, UPLC-q-ToF and GC-MS for chemical analysis and fingerprinting. Funding for biomarker research is secured via goverment allocated research funding (US, China, Saudi, Libya), EU funded collaborative projects with both academic and industry partners (EMIF-AD), UK goverment funding (MRC-NIHR National Phenome Center) and major charities funding research (Alzheimer's Association, ARUK, ROTRF).
  • Collaborations and clinical projects are to do with discovering small molecule biomarkers in clinical fields, to find early diagnosis or biochemical pathways that are implicated in the disease progressing. Also called metabolomics this technology is combined with other -omics to extract information on disease mechanisms. Current projects are to do with Alzheimer's disease and dementia, schizophrenia, metabolic syndrome, diabetes and liver disease.

Research interests (short)

Personal webpage

Brain-Liver Axis, Dementia, Translational Medicine, Biomarkers, Metabolomics and Chemical Analysis. 



Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 15 - Life on Land


Dive into the research topics where Cristina Legido Quigley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or